544 related articles for article (PubMed ID: 20699744)
1. Use of recombinant factor VIIa in US military casualties for a five-year period.
Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant activated factor VII on mortality in combat-related casualties with severe trauma and massive transfusion.
Spinella PC; Perkins JG; McLaughlin DF; Niles SE; Grathwohl KW; Beekley AC; Salinas J; Mehta S; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2):286-93; discussion 293-4. PubMed ID: 18301188
[TBL] [Abstract][Full Text] [Related]
3. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
Perkins JG; Schreiber MA; Wade CE; Holcomb JB
J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
[TBL] [Abstract][Full Text] [Related]
4. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Stein DM; Dutton RP; Kramer ME; Scalea TM
J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
[TBL] [Abstract][Full Text] [Related]
6. Recombinant factor VIIa is associated with an improved 24-hour survival without an improvement in inpatient survival in massively transfused civilian trauma patients.
Nascimento B; Lin Y; Callum J; Reis M; Pinto R; Rizoli S
Clinics (Sao Paulo); 2011; 66(1):101-6. PubMed ID: 21437444
[TBL] [Abstract][Full Text] [Related]
7. Transfusion strategies and development of acute respiratory distress syndrome in combat casualty care.
Park PK; Cannon JW; Ye W; Blackbourne LH; Holcomb JB; Beninati W; Napolitano LM
J Trauma Acute Care Surg; 2013 Aug; 75(2 Suppl 2):S238-46. PubMed ID: 23883915
[TBL] [Abstract][Full Text] [Related]
8. Anatomic distribution and mortality of arterial injury in the wars in Afghanistan and Iraq with comparison to a civilian benchmark.
Markov NP; DuBose JJ; Scott D; Propper BW; Clouse WD; Thompson B; Blackbourne LH; Rasmussen TE
J Vasc Surg; 2012 Sep; 56(3):728-36. PubMed ID: 22795520
[TBL] [Abstract][Full Text] [Related]
9. Combat Casualties and Severe Shock: Risk Factors for Death at Role 3 Military Facilities.
Buehner MF; Eastridge BJ; Aden JK; DuBose JJ; Blackbourne LH; Cestero RF
Mil Med; 2017 Sep; 182(9):e1922-e1928. PubMed ID: 28885956
[TBL] [Abstract][Full Text] [Related]
10. The effects of protocolized use of recombinant factor VIIa within a massive transfusion protocol in a civilian level I trauma center.
Morse BC; Dente CJ; Hodgman EI; Shaz BH; Nicholas JM; Wyrzykowski AD; Salomone JP; Vercruysse GA; Rozycki GS; Feliciano DV
Am Surg; 2011 Aug; 77(8):1043-9. PubMed ID: 21944521
[TBL] [Abstract][Full Text] [Related]
11. Early autologous fresh whole blood transfusion leads to less allogeneic transfusions and is safe.
Rhee P; Inaba K; Pandit V; Khalil M; Siboni S; Vercruysse G; Kulvatunyou N; Tang A; Asif A; O'Keeffe T; Joseph B
J Trauma Acute Care Surg; 2015 Apr; 78(4):729-34. PubMed ID: 25807402
[TBL] [Abstract][Full Text] [Related]
12. Increased mortality associated with the early coagulopathy of trauma in combat casualties.
Niles SE; McLaughlin DF; Perkins JG; Wade CE; Li Y; Spinella PC; Holcomb JB
J Trauma; 2008 Jun; 64(6):1459-63; discussion 1463-5. PubMed ID: 18545109
[TBL] [Abstract][Full Text] [Related]
13. Admission physiology criteria after injury on the battlefield predict medical resource utilization and patient mortality.
Eastridge BJ; Owsley J; Sebesta J; Beekley A; Wade C; Wildzunas R; Rhee P; Holcomb J
J Trauma; 2006 Oct; 61(4):820-3. PubMed ID: 17033546
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up and amputation-free survival in 497 casualties with combat-related vascular injuries and damage-control resuscitation.
Dua A; Patel B; Kragh JF; Holcomb JB; Fox CJ
J Trauma Acute Care Surg; 2012 Dec; 73(6):1517-24. PubMed ID: 23188245
[TBL] [Abstract][Full Text] [Related]
15. The Effect of a Golden Hour Policy on the Morbidity and Mortality of Combat Casualties.
Kotwal RS; Howard JT; Orman JA; Tarpey BW; Bailey JA; Champion HR; Mabry RL; Holcomb JB; Gross KR
JAMA Surg; 2016 Jan; 151(1):15-24. PubMed ID: 26422778
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant factor VIIA for control of combat-related haemorrhage.
Woodruff SI; Dougherty AL; Dye JL; Mohrle CR; Galarneau MR
Emerg Med J; 2010 Feb; 27(2):121-4. PubMed ID: 20156864
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study.
Fox CJ; Mehta SG; Cox ED; Kragh JF; Salinas J; Holcomb JB
J Trauma; 2009 Apr; 66(4 Suppl):S112-9. PubMed ID: 19359954
[TBL] [Abstract][Full Text] [Related]
19. Transfusion for shock in US military war casualties with and without tourniquet use.
Kragh JF; Nam JJ; Berry KA; Mase VJ; Aden JK; Walters TJ; Dubick MA; Baer DG; Wade CE; Blackbourne LH
Ann Emerg Med; 2015 Mar; 65(3):290-6. PubMed ID: 25458979
[TBL] [Abstract][Full Text] [Related]
20. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital.
Stinger HK; Spinella PC; Perkins JG; Grathwohl KW; Salinas J; Martini WZ; Hess JR; Dubick MA; Simon CD; Beekley AC; Wolf SE; Wade CE; Holcomb JB
J Trauma; 2008 Feb; 64(2 Suppl):S79-85; discussion S85. PubMed ID: 18376176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
